Tech Company Financing Transactions
TARIS Biomedical Funding Round
TARIS Biomedical, based in Lexington, raised $32 million from Flagship Pioneering, Polaris Partners and RA Capital.
Transaction Overview
Company Name
Announced On
10/27/2015
Transaction Type
Venture Equity
Amount
$32,000,000
Round
Undisclosed
Investors
Flagship Pioneering (Lead Investor) (Ed Kania)
Polaris Partners (Kevin Bitterman)
RA Capital (Rajeev Shah)
Proceeds Purpose
TARIS will use the proceeds from this current financing to advance an exciting new pipeline that targets a range of high unmet need bladder diseases, initially focusing on bladder cancer and overactive bladder segments.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
113 Hartwell Ave.
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Overview
TARIS Biomedical Inc., a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device convergence products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tony Kingsley
Chief Financial Officer
Diane Marcou
Chief Medical Officer
Christopher Cutie
Chief Scientific Officer
Dennis Giesing
Chief Technical Officer
Cheryl Larrivee-Elkins
Browse more venture capital transactions:
Prev: 10/27/2015: Outreach venture capital transaction
Next: 10/27/2015: Red Peach venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs